Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CCEL

CCEL - CRYO-CELL International, Inc. Stock Price, Fair Value and News

$3.38-0.08 (-2.31%)
Market Closed

28/100

CCEL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

28/100

CCEL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.73

Target 3M

$3.17

Target 6M

$2.94

CCEL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CCEL Price Action

Last 7 days

0.3%

Last 30 days

-3.1%

Last 90 days

-24.7%

Trailing 12 Months

-54.8%

CCEL RSI Chart

CCEL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CCEL Valuation

Market Cap

27.2M

Price/Earnings (Trailing)

-57.49

Price/Sales (Trailing)

0.86

EV/EBITDA

6.35

Price/Free Cashflow

4.4

CCEL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.73

Target 3M

$3.17

Target 6M

$2.94

CCEL Fundamentals

CCEL Revenue

Revenue (TTM)

31.7M

Rev. Growth (Yr)

-2.99%

Rev. Growth (Qtr)

-1.3%

CCEL Earnings

Earnings (TTM)

-473.6K

Earnings Growth (Yr)

-28.74%

Earnings Growth (Qtr)

110.64%

CCEL Profitability

EBT Margin

4.57%

Return on Equity

3.19%

Return on Assets

-0.75%

Free Cashflow Yield

22.71%

CCEL Investor Care

Dividend Yield

5.49%

Dividend/Share (TTM)

0.25

Buy Backs (1Y)

0.09%

Diluted EPS (TTM)

-0.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202532.1M32.0M31.7M0
202431.4M31.6M31.8M32.0M
202330.9M31.0M31.2M31.3M
202229.3M29.7M29.9M30.3M
202130.4M29.7M29.1M28.9M
202031.9M31.7M31.6M31.1M
201930.5M32.1M32.4M31.8M
201825.8M26.1M27.1M29.2M
201723.8M24.2M24.8M25.4M
201621.4M22.2M23.1M23.1M
201519.6M19.8M20.3M21.1M
201419.7M19.7M19.9M20.1M
201318.4M18.8M19.1M19.0M
201217.6M17.4M17.6M18.0M
201117.8M17.8M17.9M17.9M
201000017.8M
Get all data in R, Python etc through our Historical Stock Data APIs

About CRYO-CELL International, Inc.

CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
 CEO
 WEBSITEcryo-cell.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES80

CRYO-CELL International, Inc. Frequently Asked Questions

CCEL is the stock ticker symbol of CRYO-CELL International, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of CRYO-CELL International, Inc. is 27.23 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CCEL's fair value in chart for subscribers.

The fair value guage provides a quick view whether CCEL is over valued or under valued. Whether CRYO-CELL International, Inc. is cheap or expensive depends on the assumptions which impact CRYO-CELL International, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CCEL.

As of Wed Jan 28 2026, CCEL's PE ratio (Price to Earnings) is -57.49 and Price to Sales (PS) ratio is 0.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CCEL PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, CRYO-CELL International, Inc. has provided 0.012 (multiply by 100 for percentage) rate of return.